I hear you re the price.
Potential for CHM to pursue a fast track approval trial if the GBM phase 1 goes well. And that is their plan. GBM has an unmet need, so its a possibility if the drug works.
As I have said, even at $1 CHM has a market cap that IMU had at 9c (check that, at itialian place for dinner so off the top of my head)
Ann: Response to ASX Query, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
